These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2495588)

  • 1. Effects of anti-L3T4 and anti-LYT2 monoclonal antibody therapy on cardiac allograft survival in presensitized recipients.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1022. PubMed ID: 2495588
    [No Abstract]   [Full Text] [Related]  

  • 2. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression by anti-CD8 (Ly-2.1) MAb conjugated to idarubicin: studies in the mouse heart graft model.
    Mottram PL; Pietersz GA; Purcell LJ; Clunie GJ; McKenzie IF
    Transplant Proc; 1990 Oct; 22(5):2111-2. PubMed ID: 2120812
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of murine cardiac allografts following treatment of graft recipients with monoclonal anti-L3T4 and Ly-2 antibodies.
    Mottram PL; Wheelahan J; Mirisklavos A; Clunie GJ; McKenzie IF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):582-5. PubMed ID: 3103281
    [No Abstract]   [Full Text] [Related]  

  • 6. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-T cell monoclonal antibodies for in vivo treatment of cardiac allograft rejection in mice.
    Mottram PL; Smyth M; Pietersz GA; Clunie GJ; McKenzie IF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1020-1. PubMed ID: 2650063
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
    J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z; Cobbold S; Waldmann H; Metcalfe S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolongation of islet isograft survival in diabetic NOD mice by anti-L3T4 and anti-LYT2 monoclonal antibodies.
    Matsuo S; Mullen Y; Wicker LS; Peterson LB; Nagata M; Tsunoda T; Clare-Salzler M
    Transplant Proc; 1990 Apr; 22(2):880-1. PubMed ID: 2109427
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
    Mottram PL; Pietersz GA; Purcell LJ; Krauer K; McKenzie IF
    Transplant Proc; 1992 Oct; 24(5):2301. PubMed ID: 1413068
    [No Abstract]   [Full Text] [Related]  

  • 12. Deletion of graft reactive cells by idarubicin-anti-CD8 (Ly-2.1) immunoconjugate: studies in the mouse heart graft model.
    Mottram PL; Pietersz GA; Purcell LJ; Krauer K; Clunie GJ; McKenzie IF
    Transplant Proc; 1991 Feb; 23(1 Pt 1):499-500. PubMed ID: 1899311
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion.
    Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE
    Transplantation; 1993 Feb; 55(2):412-7. PubMed ID: 8094583
    [No Abstract]   [Full Text] [Related]  

  • 17. The synergistic effect of anti-CD4 monoclonal antibodies and cyclosporin A on murine fetal islet allograft survival.
    Burkhardt K; Charlton B; Mandel TE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2663-4. PubMed ID: 2495663
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of an anti-CD3 priming dose to enhance the immunosuppressive potency of monoclonal and polyclonal T-cell antisera.
    Sherburne CG; Onyekaba CO; Condie RM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):626-9. PubMed ID: 1824996
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma.
    Hancock W; Mottram PL; Purcell LJ; Han WR; Pietersz GA; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2937-8. PubMed ID: 8212290
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):3991-2. PubMed ID: 3313979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.